Interventional Clinical Trial Comparing Kerecis Omega3 Wound Versus SOC in Diabetic Foot Wounds

NACompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

July 2, 2020

Primary Completion Date

July 9, 2022

Study Completion Date

December 16, 2022

Conditions
DiabetesDiabetic Foot Ulcer
Interventions
DEVICE

Kerecis Omega3 Wound

Treatment of the wound with Kerecis Omega3 Wounds matrices

Trial Locations (12)

14033

CHU de Caen, Caen

21000

CHU de Dijon - Bocage Sud, Dijon

31059

CHU de Toulouse Hôpital Rangueil, Toulouse

34295

CHU de Montpellier, Montpellier

44093

CHU de Nantes Hôpital Nord Laennec, Saint-Herblain

51100

CHU de Reims - Hôpital Debré, Reims

59100

Hôpital de Roubaix - CETRADIM, Roubaix

67091

CHRU de Strasbourg - Hopital Civil, Strasbourg

71200

Hotel Dieu Le Creusot, Le Creusot

75014

Hôpital Cochin, Paris

75018

Hopital Bichat-Claude Bernard, Paris

91100

Centre Hospitalier Sud Francilien, Corbeil-Essonnes

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Kerecis Ltd.

INDUSTRY

collaborator

RCTs

INDUSTRY

collaborator

Clininfo S.A.

INDUSTRY

lead

Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète

OTHER

NCT04537520 - Interventional Clinical Trial Comparing Kerecis Omega3 Wound Versus SOC in Diabetic Foot Wounds | Biotech Hunter | Biotech Hunter